Can you say "most effective" in Indian pharma promotional material?
Restricted. The superlative 'most effective' is restricted in Indian pharmaceutical promotion to doctors under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024. The claim must be balanced and verifiable, must not mislead, and must be capable of substantiation (Clause 1.3). A comparison must be factual, fair and capable of substantiation (Clause 2.4). Prefer specific, evidence-based wording. One example is 'demonstrated superior [endpoint] versus [comparator, by generic name] in [study and population]'.
In short
- Status: restricted.
- Governing instrument: Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, Clause 1.3, on information that is balanced, up-to-date, verifiable and capable of substantiation and does not mislead. Also Section 2 (Claims & Comparisons), Clauses 2.1 and 2.4, and Clause 2.5 where another company's brand is named.
- UCPMP 2024 does not name this term.
- First checked by two independent AI models against the live web. Citations re-checked on 6 October 2026. They were checked against the official text of the Code.
Which instrument governs this
Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, Clause 1.3, on information that is balanced, up-to-date, verifiable and capable of substantiation and does not mislead. Also Section 2 (Claims & Comparisons), Clauses 2.1 and 2.4, and Clause 2.5 where another company's brand is named.
UCPMP 2024 does not name this phrase. As a superlative it implies a comparison with every alternative. So it needs comparative evidence that is factual, fair and capable of substantiation (Clause 2.4). Without that evidence, changing the word does not fix the claim.
What verification returned
The superlative 'most effective' is restricted in Indian pharmaceutical promotion to doctors under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024. The claim must be balanced and verifiable, must not mislead, and must be capable of substantiation (Clause 1.3). A comparison must be factual, fair and capable of substantiation (Clause 2.4). Prefer specific, evidence-based wording. One example is 'demonstrated superior [endpoint] versus [comparator, by generic name] in [study and population]'. Another is wording consistent with the label, such as 'effective for [indication] as approved'. Naming another company's brand in a comparison needs that company's prior consent (Clause 2.5).
How this was checked
Two independent AI models were asked the same question against the live web. They were Gemini 2.5 Pro with Google Search grounding, and OpenAI GPT-5 with web search. A third model then judged whether they agreed on the substance rather than the wording. Every source cited was fetched over HTTP to confirm it exists. A fetch confirms only that a source exists. It does not confirm that the source supports the statement. So on 6 October 2026 the citations on this page were re-checked. They were checked against the official text of the Code. They were corrected where they were wrong. Terms that did not reach agreement between the models are not published.
Sources checked
Frequently asked questions
Can you say "most effective" in pharma promotion in India?
Restricted. The superlative 'most effective' is restricted in Indian pharmaceutical promotion to doctors under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024. The claim must be balanced and verifiable, must not mislead, and must be capable of substantiation (Clause 1.3). A comparison must be factual, fair and capable of substantiation (Clause 2.4). Prefer specific, evidence-based wording. One example is 'demonstrated superior [endpoint] versus [comparator, by generic name] in [study and population]'.
Which code governs the use of 'most effective'?
Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, Clause 1.3, on information that is balanced, up-to-date, verifiable and capable of substantiation and does not mislead. Also Section 2 (Claims & Comparisons), Clauses 2.1 and 2.4, and Clause 2.5 where another company's brand is named.
How reliable is this answer?
It was first checked on 10 September 2026 by two independent AI models, Gemini 2.5 Pro and GPT-5. Both worked against the live web, and their answers were adjudicated for agreement. Every cited source was fetched to confirm it exists. A fetch confirms only that a source exists. So on 6 October 2026 the citations were re-checked. They were checked against the official text of the Code. They were corrected where they were wrong. Terms that did not reach agreement are not published. The Code can change, so check against the source before relying on it.
Check it before MLR does
Collateral Advisor flags this term in the pages you upload, for your team to review in context.
Free trial, no card needed. MarketingSense is a pre-MLR advisory assistant. Your medical, legal and regulatory team still makes the final call.